Spondyloarthritis (SpA) is the most common extraintestinal manifestation of IBD. SpA symptoms are not always recognized in patients with IBD. Subsequently, patients with symptoms of SpA can be underdiagnosed, with effective treatment delayed. Cooperation between gastroenterologists and rheumatologists is necessary and, ideally, an integrated management of these patients should be adopted.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro
Journal of Translational Medicine Open Access 25 August 2023
-
Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS)
Arthritis Research & Therapy Open Access 18 March 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Arvikar, S. L. & Fisher, M. C. Inflammatory bowel disease associated arthropathy. Curr. Rev. Musculoskelet. Med. 4, 123–131 (2011).
van Erp, S. J. H. et al. Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow up study. J. Crohns Colitis http://dx.doi.org/10.1093/ecco-jcc/jjv195.
Rudwaleit, M. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25–31 (2011).
Salvarani, C. & Fries, W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J. Gastroenterol. 15, 2449–2455 (2009).
Dougados, M. et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 34, 1218–1227 (1991).
Rodríguez-Reyna, T. S., Martínez-Reyes, C. & Yamamoto-Furusho, J. K. Rheumatic manifestations of inflammatory bowel disease. World J. Gastroenterol. 15, 5517–5524 (2009).
Smale, S., Natt, R. S., Orchard, T. R., Russell, A. S. & Bjarnason, I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum. 44, 2728–2736 (2001).
Mandl, P. et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann. Rheum. Dis. 74, 1327–1339 (2015).
Stolwijk, C. et al. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease. Can. J. Gastroenterol. 27, 199–205 (2013).
Olivieri, I. et al. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun. Rev. 13, 822–830 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gionchetti, P., Rizzello, F. IBD and spondyloarthritis: joint management. Nat Rev Gastroenterol Hepatol 13, 9–10 (2016). https://doi.org/10.1038/nrgastro.2015.208
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.208
This article is cited by
-
CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro
Journal of Translational Medicine (2023)
-
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
Drugs (2021)
-
Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS)
Arthritis Research & Therapy (2020)